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Abstract
Background: Control of intercellular penetration of microbial products is critical for the barrier
function of oral epithelia. We demonstrated that CD24 is selectively and strongly expressed in the
cells of the epithelial attachment to the tooth and the epithelial lining of the diseased periodontal
pocket and studies in vitro showed that CD24 regulated expression of the epithelial intercellular
adhesion protein E-cadherin.
Results: In the present study, the barrier function of oral epithelial cell monolayers to low
molecular weight dextran was assayed as a model for the normal physiological function of the
epithelial attachment to limit ingress of microbial products from oral microbial biofilms. Paracellular
transfer of low molecular weight dextran across monolayers of oral epithelial cells was specifically
decreased following incubation with anti-CD24 peptide antibody whereas passage of dextran
across the monolayer was increased following silencing of mRNA for CD24. Changes in barrier
function were related to the selective regulation of the genes encoding zonula occludens-1, zonula
occludens-2 and occludin, proteins implicated in tight junctions. More particularly, enhanced
barrier function was related to relocation of these proteins to the cell periphery, compatible with
tight junctions.
Conclusion: CD24 has the constitutive function of maintaining expression of selected genes
encoding tight junction components associated with a marginal barrier function of epithelial
monolayers. Activation by binding of an external ligand to CD24 enhances this expression but is
also effective in re-deployment of tight junction proteins that is aligned with enhanced intercellular
barrier function. These results establish the potential of CD24 to act as a potent regulator of the
intercellular barrier function of epithelia in response to local microbial ecology.
Background
Mechanisms responsible for the maintenance of the epi-
thelial barrier critical for normal function in the gastroin-
testinal tract have been incompletely understood [1], with
increasing interest in the barrier function of mucosal sur-
faces. In the oral cavity the epithelia attachment to the
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tooth presents a particular challenge as this is the only tis-
sue environment where the eruption of teeth effectively
results in a permanent breach in the integrity of the integ-
ument. In the process of tooth eruption the remnant of
the epithelium responsible for secretion of the organic
matrix of enamel melds with a down-growth of the oral
epithelium to generate the epithelial attachment to the
tooth [2]. CD24 is selectively strongly expressed by the
epithelial attachment to the tooth and by the epithelium
lining of the lesion of chronic periodontitis. This antigen
is recognized by auto-reactive serum antibodies in
patients with chronic periodontal disease [3] and
increased titres of antibodies reactive with CD24 peptide
correlated with more favourable diagnosis, suggesting a
protective effect [3]. CD24 is a heavily glycosylated pep-
tide ligand for vascular P-selectin and is anchored by
phosphoinositol linkage to lipid rafts within the cell
membrane [4]. It has been shown to be a regulator of the
chemokine CXCR4 [5] and CD24 mediates expression of
cell adhesion molecules in B lymphocytes with evidence
for a signaling function for the CD24 receptor provided by
the regulation of apoptosis in B cell precursors by mono-
clonal antibodies reactive with CD24 [6]. Isoforms of
CD24 expressed as 33–35 kDa and 30 kDa entities typi-
cally contain N-glycosylation patterns including α2,3-
sialic acid groups as primary sites for recognition by the L1
transmembrane receptor [7] that is also expressed by the
epithelial attachment to the tooth and that lining the
lesion of periodontitis (unpublished data). Intra- and
inter-cellular signaling occurring through interaction
between CD24 and L1 could be modulated by lectin-like
molecules such as the sialic acid binding protein Hsa from
Streptococcus gordonii, an early coloniser in bacterial
plaque [8], or by antibodies that recognize CD24 [3].
These ligands for CD24 have potential to either activate
signaling through CD24 or perturb signals mediated by
constitutive interaction between CD24 and L1.
The reactive epithelium associated with inflammatory
periodontal disease has a number of features that distin-
guish it from stratified squamous epithelia in other sites
in the body. These include cytokeratin [9] and involucrin
[10] expression profiles that do not support a typical pat-
tern of terminal differentiation, reduced expression of E-
cadherin and perturbation of F-actin filament structure
[10]. This epithelium supports the transmigration of neu-
trophil polymorphonuclear leukocytes as a critical ele-
ment of defence against the adjacent microbial biofilm
[2]. Immuno-pathological responses to bacterial antigens
are considered to be central in the pathogenesis of the
destructive disease of periodontitis where the normal
structure of the epithelium is perturbed [10] with evi-
dence that cytokines released by adjacent inflammatory
infiltrate cells act to disrupt epithelial tight junctions [11]
responsible for barrier function to exclude low molecular
weight microbial products.
The current consensus model for lining epithelium indi-
cates initial cell-cell adhesion mediated by the cadherin
complex as a key pre-requisite for the establishment of
other types of cell junctions and of epithelial polarity; a
property initially assigned to highly aligned epithelia such
as the intestinal lining but more recently recognised to
occur to a degree in most lining epithelia including the
epidermis [12] and non-keratinised oral epithelial tissues
[13,14]. The presence of tight junctions in normal strati-
fied epithelia, metaplastic stratified epithelia and cultured
derivatives of these tissues, has been a subject of contro-
versy [14]. Functional studies have indicated the impor-
tance of claudin-1 expression in the permeability barrier
of the epidermis of newborn mice [15] and Langbein et al.
[14] have described a range of morphological types of
close intercellular contacts associated with localisation of
tight junction proteins in diverse mucosal sites.
E-cadherin association with the actin cytoskeleton is
mediated by catenins and this complex also localizes the
partitioning defective par-3/par-6/atypical PKC polarity
complex [16]. Activation of this complex mediated by
binding to the small GTPase Cdc42 results in phosphor-
ylation and activation of atypical PKC. This pathway is
considered to be important in promoting the appropriate
formation of tight junction complexes possibly initiated
by the binding of zonula occludens-1 (ZO-1) and zonula
occludens-2 (ZO-2) to catenin. ZO-1 and ZO-2 function
as sub-membrane anchors for the tight junction compo-
nents occludin and the claudins [17]. Components of the
intercellular junction structure include occludin [18] and
the claudins comprising an extensive family of twenty
four proteins [19]. The claudin composition of the tight
junction defines the particular properties of the junction
[20] with claudins-1, -2, -3, -4 and -7 reported to be prom-
inent in stratified epithelia [21].
In the culture model used in previous study [22], H413
oral epithelial cells responded to specific suppression of
CD24 mRNA and the associated reduction of surface
CD24 protein by down-regulating e-cadherin expression.
Ligation of CD24 on H413 cells by monoclonal antibod-
ies to CD24 peptide resulted in strong stimulation of E-
cadherin mRNA expression [22]. The objective of the
present study was to investigate the potential for CD24 to
regulate barrier function of oral epithelial monolayers in
order to define mechanisms underlying the physiological
function of the highly specialized epithelium of the peri-
odontal attachment as the initial component responsible
for the microbial barrier function of the oro-gastro-intes-
tinal tract.BMC Cell Biology 2009, 10:2 http://www.biomedcentral.com/1471-2121/10/2
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Results and discussion
Anti-CD24 peptide antibody reduces passage of dextran 
across the epithelial monolayers
Monolayers were cultured to confluence on membranes
within diffusion chambers as described in Methods. The
accumulation of labeled dextran in the lower chamber
measured at time points showed H413 monolayers were
impermeable to high molecular weight dextran tetrameth-
ylrhodamine (TMR, 2 MDa), indicating the integrity of
the monolayer but were permeable to low molecular
weight dextran Alexa Fluor 647 (10 kDa). Relative to iso-
type control antibody, addition of anti-CD24 peptide
antibody resulted in a significant reduction in the accu-
mulation of low molecular weight dextran in the lower
chamber (Figure 1).
Altered gene expression of tight junctions mediated by 
anti-CD24 peptide antibody
Reduced transfer of low molecular weight marker to the
lower chamber suggested tight junction function. The
responses to anti-CD24 peptide antibody, of genes encod-
ing tight junction proteins commonly expressed in strati-
fied epithelia [21], were screened and analysed by RT-PCR
arrays (Figure 2A and 2B). Significant up-regulation of
genes encoding ZO-1, ZO-2, occludin and par-3 (Figure
2B) was validated by quantitative real-time RT-PCR (Table
1). Expression of par-6 and claudin-3, not detected in con-
trol cultures by 30 cycles of PCR, was demonstrable fol-
lowing challenge with anti-CD24 peptide antibody
(Figure 2A and 2B). Gene expression for claudin-3 and
par-6 was not detected in control samples by real-time
quantitative RT-PCR analysis (Table 1).
Changes in barrier formation of epithelial monolayers 
related to both increased levels and peripheral 
deployment of ZO-1, ZO-2, occludin and claudin-7
Cell lysates were probed with antibodies to tight junction
proteins in Western blot analysis to confirm that the
increase in gene expression was manifest as up-regulation
of tight junction proteins. The data presented in Figure 3A
and 3B indicate a significant increase in levels of ZO-1,
ZO-2 and occludin in cultures challenged with anti-CD24
antibody. Par-6 and claudin-3 were not detected in either
control or anti-CD24 treated cultures. Probing for clau-
din-7 indicated multiple bands in extracts of anti-CD24
treated cultures (Figure 3C) whereas a single reactive
product was detected for cultures challenged with isotype
control antibody. Multimers of claudins have been
reported [23] and also complexes of claudin-7 with
EpCAM, a pan-epithelial, homophilic intercellular adhe-
sion molecule [24]. EpCAM was reported to form tight
associations with claudin-7 that resist dissociation in SDS
PAGE and result in a range of molecular weight entities
detected by anti-claudin-7 antibodies [24]. It is possible
that stimulation through CD24 induced complex forma-
tion of claudin-7 with EpCAM resulting in stabilization of
the protein. This would explain the greater abundance of
claudin-7 following stimulation with anti-CD24 antibody
despite the lack of evidence for increase in mRNA expres-
sion for this product (Figure 2B and Table 1).
Confocal microscopy confirmed that while there was evi-
dence from Western blot of moderate increase in tight
junction protein expression in cultures challenged with
anti-CD24 peptide antibody (Figure 3), there were
marked changes in distribution from focal plaques or dif-
fuse cytoplasmic staining in control cultures to continu-
ous deposition at cell borders following challenge with
anti-CD24 peptide antibody (Figure 4). Occludin, a com-
ponent of the intercellular junction structure [18], was
redistributed from a diffuse cytoplasmic pattern to a well-
defined cell border pattern noted to be continuous by
three hours after anti-CD24 antibody treatment. In con-
trast, ZO-1 was rearranged from a focal peripheral pattern
to a continuous cell border pattern in keeping with its role
as a sub-membrane anchor for tight junction components
[17]. Although a similar role has been described for ZO-2,
changes for this protein were less marked and the distribu-
tion pattern in cells challenged with anti-CD24 antibody
was not uniform. The changes are compatible with pro-
tein kinase activity reported [25] to be implicatedin driv-
ing appropriate location of tight junction proteins.
Claudin-7 showed both cytoplasmic and cell membrane
localisation in cultures treated with either anti-CD24 anti-
body or isotype control antibody but with increased
intensity of staining (Figure 4) in anti-CD24 challenged
cultures.
Examination of the claudin-7 frame counter-stained with
DAPI indicates that the claudin-7 network is located at a
deeper plane as revealed by confocal optical sectioning.
This finding could be explained by the report of localisa-
tion of claudin-7 to basolateral membrane complexes in
association with tetraspanins [24] that are removed from
the area of tight junctions [23]. While the present findings
do not confirm a direct contribution of claudin-7 to the
observed barrier function, membrane localised claudin-7
is reported to regulate E-cadherin expression [26], disclos-
ing an indirect mechanism of support for effective junc-
tions. Confocal imaging for par-6 and claudin-3 did not
reveal the localisation of these molecules. These findings
establish that stimulation by anti-CD24 induces selective
up-regulation of components of tight junctions but more
apparently, re-distribution of ZO-1, ZO-2 and occludin to
the cell periphery where it is possible that the formation
of functional tight junction complexes is responsible for
the enhanced barrier function observed. The contribution
of claudins, regarded as essential tight junction compo-
nents, was not confirmed in this analysis.BMC Cell Biology 2009, 10:2 http://www.biomedcentral.com/1471-2121/10/2
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Distribution of F-actin supports the peripheral deployment 
of tight junction proteins
Cultures treated with isotype control antibody demon-
strated scattered cells with typical F-actin filaments
extending through the long axis of the cell but with most
cells displaying concentration of F-actin in regions of the
cell periphery (Figure 5A). In contrast, cultures treated
with anti-CD24 antibody demonstrated more uniform
Tight junction barrier function assayed in H413 clone-1 epithelial cell monolayers treated with anti-CD24 peptide antibody Figure 1
Tight junction barrier function assayed in H413 clone-1 epithelial cell monolayers treated with anti-CD24 pep-
tide antibody. Antibody to CD24 reduces passage of fluorochrome-labelled dextran across H413 epithelial cell monolayers. 
Due to passage of dextran into the lower compartment reaching equilibrium after the 7th hour, the rate of transfer was calcu-
lated over the first 5 hours. Regression analysis representative of three independent experiments for time points from tripli-
cate cultures (showing mean values ± s.e.m.). Cultures were permeable for the translocation of low molecular weight dextran 
(Alexa Fluor 647 10 kDa, ** refers to P < 0.01, paired t-test), but were impermeable to high molecular weight dextran tetram-
ethylrhodamine (TMR, 2 MDa).
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distribution with greater intensity of F-actin localised to
the periphery of the cells (Figure 5B). The findings indi-
cate a rapid and specific re-organisation of F-actin fila-
ments in anti-CD24 antibody-treated cultures to support
intercellular junctions.
Ultrastructural analysis
Cross-sections of semi-thin sections stained with Toluid-
ine blue indicated changes in morphology following chal-
lenge with anti-CD24 antibody. Cultures determined to
be confluent by phase contrast microscopy, showed, at 3
h after incubation with isotype control antibody, mostly
flattened cells with intercellular contacts localised to the
region adjacent to the polyester membrane. Cultures chal-
lenged with anti-CD24 antibody contained a majority of
cells with raised profile and more extensive intercellular
contacts.
Low magnification was used to evaluate the nature of
intercellular contacts for those cultures challenged with
anti-CD24 antibody versus isotype control antibody. It
was observed for preparations sectioned en face that abun-
dant cell processes were more uniformly distributed in
cultures treated with anti-CD24 antibody (Figure 6D and
Figure 6A). Close contacts in the basal regions abutting
the supporting polyester membrane (Figure 6B and 6C)
were evident in cross-sections of cutures challenged with
isotype control antibody. In contrast, cultures treated with
anti-CD24 antibody exhibited more extensive close con-
tacts between processes of adjacent cells (Figure 6E).
These contacts were characterised by intense staining of
adjacent membranes, frequently in proximity to desmo-
somes. In cultures treated with anti-CD24 antibody, close
membrane contacts included extended junctions (Figure
6F) characteristic of occludin-containing junctions in
stratified epithelia and cultured derivatives of these tissues
[14]. Similar structural entities were not detected in cul-
tures treated with isotype control antibody despite fre-
quent observation of regions of close intercellular contact
(Figure 6C). Description of the distribution of proteins in
the intercellular bridges of tight junctions of stratified
mucosal epithelia has emerged only recently based on
immunohistochemical and ultrastructural analysis
[14,27].
CD24 regulates transcription of genes encoding tight 
junction proteins in un-stimulated epithelial cultures
To determine if CD24 was important in maintaining basal
levels of expression of genes encoding tight junction pro-
teins an RNA interference strategy was employed as
described in the Methods. Analysis of extracted mRNA
indicated selective suppression of ZO-1, ZO-2, occludin,
claudin-7 and par-3 expression (Figure 7B and 7C) that
was confirmed by quantitative real-time RT-PCR (Table
2), with the degree of suppression correlating with the
effectiveness of siRNA inserts in down-regulating CD24
mRNA (see Figure 7). This data indicated that CD24 func-
tions normally to maintain levels of expression of selected
genes encoding tight junction components. A potential
mechanism is by signaling mediated by intra- and inter-
cellular interaction of CD24 with L1 that is also expressed
by these epithelial cells (data not shown). A high degree
of inverse correlation was evident between those genes
up-regulated by anti-CD24 treatment (Figure 2A and 2B)
and down-regulated following silencing of CD24 expres-
sion (Figure 7B and 7F). Effective silencing of CD24
expression was associated with enhanced expression of
snail, twist and tgf-β3 in this model [22]. Over-expression
of Snail in an epithelial model also potently down-regu-
lated expression of occludin, claudin-3, claudin-4 and clau-
din-7 accompanied by disruption of tight junctions and
adherens junctions [28], providing a plausible link to
explain the findings from the present study. Effective
down-regulation of CD24 was associated with a short-
term increase in permeability of the epithelial monolayer
to low molecular weight dextran (Figure 8). This data sug-
gested that CD24 maintains a minimal barrier function in
un-stimulated cells.
Conclusion
In summary, CD24 levels observed in un-treated H413
clone-1 cells [22] are required to maintain moderate levels
of expression of selected genes encoding tight junction
components. This function did not support uniform
Table 1: Real-time quantitative RT-PCR analysis of changes in expression of genes encoding tight junction proteins in response to anti-
CD24 peptide antibody
Gene Ratio of average gene of interest 
(GOI): Test (CD24 peptide antibody treatment)/Control (IgG1 negative antibody)
Paired t-test
P value (two tailed)
ZO-1 1.98 < 0.05
ZO-2 1.5 < 0.05
occludin 1.24 < 0.001
claudin-3 Not detected in controls
claudin-7 1.05 > 0.05
par-3 1.81 < 0.01
par-6 Not detected in controlsBMC Cell Biology 2009, 10:2 http://www.biomedcentral.com/1471-2121/10/2
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Figure 2 (see legend on next page)
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peripheral deployment of the corresponding tight junc-
tion proteins but it was associated with a limited barrier
function of the monolayer in restricting the passage of low
molecular weight dextran. Silencing of CD24 expression
was previously linked to down-regulation of E-cadherin
[22]. Findings from the present study indicated the addi-
tional effect of down-regulating the expression of selected
tight junction components could be responsible for the
permeability changes observed. In this study, a mono-
clonal antibody to CD24 peptide was used to mimic the
potential action of auto-reactive antibodies to CD24. The
effect was to increase the synthesis of ZO-1, ZO-2 and
occludin, but a more pronounced consequence was the re-
deployment of these proteins to the cell periphery. For
occludin, ZO-1 and ZO-2, the arrangement was compati-
ble with tight junction formation whereas claudin-7 was
distributed in a different manner. These changes were
associated with substantial improvement of barrier func-
tion that was compatible with effective tight junctions.
While the data indicate that CD24 has an important role
in regulating expression of tight junction components,
activation by an external ligand was necessary to induce a
second function, the deployment of the proteins to the
cell periphery associated with enhanced barrier function.
The mechanisms for these two distinct functionalities
remain to be explored.
Methods
Oral epithelial cell culture
The epithelial cell line (H413) derived from a human oral
squamous cell carcinoma [29], displays stratified epithe-
lial cell morphology in culture. H413 cell clonal lines
were established using a limit dilution method as
described previously [22]. H413 clone-1 cells exhibiting
both characteristic epithelial morphology and high CD24
expression were chosen for this study. This clone was typ-
ical of more than half of the 50 clones that were success-
fully established indicating that it was broadly
representative of the H413 cell line with respect to these
characteristics. The cloned cells were cultured in Eagle's
Minimum Essential Medium (MEM, Joklik modification,
Sigma) and 5% fetal calf serum (FCS, CSL Limited, Victo-
ria, Australia) {0.2 mM calcium contributed from FCS-
[30]} at 37°C in 5% CO2. Cultures were harvested with
0.05% trypsin/EDTA in PBS and sub-cultured every 3
days.
CD24 siRNA preparation and transfection of H413 clone-
1 cells
The CD24 siRNA insert-1, 5'-TCCAACTAATGCCACCAC-
CAA-3' (GenBank accession no. M58664), established as
the most effective in specific suppression of mRNA for
CD24 in H413 clone-1 cells was validated according to
the protocol detailed in our earlier report [22]. This CD24
siRNA insert reduced CD24 mRNA in H413 clone-1 cells
by an average of 90% and did not activate expression of
the interferon response gene OAS1 [22]. The CD24 siRNA
insert-2, 5'-GTCTCTTCG TGGTCTCACTC-3' was less
effective (72–85%) in silencing CD24 mRNA. The CD24
siRNA insert-3, 5'-GCATCCTGAGCAACTCTTGAT-3' did
not produce detectable silencing of CD24 mRNA level.
The barrier function of epithelial cell monolayers
Barrier function of tight junctions in oral epithelial cells
was measured by plating H413 clone-1 cells in 24 mm
Transwell filters on 0.4 μm pore size polyester membranes
(Corning Incorporated Life Science, USA). Briefly, 2.6 ml
of medium was added to the lower compartment and 1.5
ml containing H413 clone-1 cells or cells transfected with
CD24 siRNA or cells transfected with control plasmid,
into the upper compartment. Cultures became confluent
(cell density: 3.2 × 104/cm2) by 48 hours when antibody
(5 μg/ml) to CD24 peptide (IgG1, ALB9, Abcam, Cam-
bridge, UK) which recognized a short non-glycosylated
peptide sequence close to the site of GPI linkage of the
peptide core of the cluster-w4/CD24 antigen [31] or the
same isotype IgG1 negative control (DAKO, Denmark)
was added to the upper chambers of randomly selected
triplicate confluent monolayers together with low molec-
ular weight dextran Alexa Fluor 647 (10 kDa Molecular
Probes, Invitrogen) diluted 1:50 from a stock solution of
1 mg/ml in medium or high molecular weight dextran
tetramethylrhodamine (TMR, 2 MDa Molecular Probes,
Invitrogen) diluted 1:20 from a stock solution of 2 mg/ml.
Dextrans were selected as bacterial products that are not
taken up by epithelial cells and therefore are translocated
Reverse transcription (RT)-PCR arrays for gene expression of tight junction proteins in response to challenge of H413 epithe- lial monolayers with anti-CD24 antibody Figure 2 (see previous page)
Reverse transcription (RT)-PCR arrays for gene expression of tight junction proteins in response to challenge 
of H413 epithelial monolayers with anti-CD24 antibody. (A) H413 clone-1 cells challenged with anti-CD24 peptide 
compared to isotype IgG1 control antibody for RNA extracted 3 h after addition of antibody. RT-PCR (30 cycles) reaction 
products were visualized on a 2% agarose gel after staining with ethidium bromide (representative of three separate experi-
ments). (B) Bar graph showing mean values from three independent experiments (± s.e.m.) for anti-CD24 peptide antibody 
studies. The values for each experiment were normalized against the expression of β-actin (assigned as 100) and compared 
with the control sample and analyzed by paired t-test. * Refers to P < 0.05; four tight junction genes: ZO-1, ZO-2, occludin and 
par-3 showed significant differences that were confirmed by real-time quantitative RT-PCR analysis in Table 1. Expression of 
genes encoding claudin-3 and par-6 was not detected in control samples by real-time quantitative RT-PCR analysis.BMC Cell Biology 2009, 10:2 http://www.biomedcentral.com/1471-2121/10/2
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Western blot analysis for representative tight junction proteins extracted from H413 clone-1 cell monolayers Figure 3
Western blot analysis for representative tight junction proteins extracted from H413 clone-1 cell monolayers. 
Data shown are representative of three independent experiments. Protein loading controls were confirmed by β-actin stain. 
(A) Showing increased expression of tight junction proteins ZO-1 (210 kDa), ZO-2 (160 kDa) and occludin (65 kDa) in cul-
tures treated with anti-CD24 peptide antibody compared to H413 monolayers treated with isotype IgG1 (5 μg/ml) control 
antibody. (B) Bar graph confirmed increased expression of ZO-1, ZO-2 and occludin in anti-CD24 antibody treated sample 
compared to isotype control antibody by paired t-test (* Refers to P < 0.05). (C) Showing multiple bands in cultures treated 
with anti-CD24 peptide antibody for claudin-7 compared to H413 monolayers treated with isotype IgG1 (5 μg/ml) control 
antibody (see explanation: Results and discussion). Specific bands were not detected for claudin-3 or par-6 in either isotype 
control or anti-CD24 antibody-challenged culture extracts.
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Figure 4 (see legend on next page)
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by paracellular diffusion through intercellular junctions.
At various time points (1–7 h, 9 h, 12 h) after commenc-
ing the experiments, 50 μl media were taken from each
lower and higher compartment, and analysed for fluores-
cence using a Perkin-Elmer LS50B luminescence spec-
trometer, Ex650 nm/Em668 nm for Alexa Fluor 647,
Ex555 nm/Em580 nm for TMR. Transfer of labelled dex-
tran was calculated as moles of fluorophore transferred to
the lower compartment determined by reference to a
standard curve. Data from 3 independent experiments
were analysed by paired t-test.
RNA extraction and reverse transcription (RT)-PCR arrays
Showing representative confocal laser scanning slice images for tight junction proteins Figure 4 (see previous page)
Showing representative confocal laser scanning slice images for tight junction proteins. Stimulation with anti-
CD24 peptide antibody led to increases in tight junction proteins and altered cellular localization patterns indicative of func-
tional tight junction complexes. Cells were grown on permeable Transwell filters until confluence as described in Methods. 
Data are representative of three independent experiments. (A) Phase contrast images showing confluence of cultures (cell den-
sity: mean value 3.2 × 104/cm2) at 3 h after challenged with isotype control antibody (left) and with CD24 peptide antibody 
(right) prior to fixation. (B) Left panel shows confocal optical sections of representative monolayers that were challenged with 
isotype control antibody for 3 h before processing: (a) staining with mouse isotype control antibody; (b) tight junction protein 
marker ZO-1 showing focal staining principally at cell borders; (c) tight junction protein marker ZO-2 showing scattered cyto-
plasmic reaction; (d) occludin showing very weak reaction; (e) claudin-7 showing faint peripheral location. Right panel shows 
confocal optical sections of representative monolayer cultures that were challenged with anti-CD24 peptide antibody for 3 h 
before processing: (f) negative control show trace non-specific staining with mouse isotype control antibody; (g) ZO-1 well 
formed and localized at cell-cell contact; (h) ZO-2 expressed in 60 percent of the area of an optical section; (i) occludin show-
ing peripheral distribution compared to trace cytoplasmic staining in monolayers exposed to control antibody (see d); (j) clau-
din-7 showing strong reaction that is diffuse near the cell periphery. This optical section image was captured at a deeper level. 
Claudin 3 and par-6 were not detected in isotype control or anti-CD24 antibody treated cultures. Bars, 20 μm. Note that the 
optical images were captured at a level corresponding to maximum staining in each case.
F-actin re-distribution in response to challenge with anti-CD24 antibody Figure 5
F-actin re-distribution in response to challenge with anti-CD24 antibody. Showing representative confocal optical 
slice images. (A) Cultures prepared 3 h after challenged with isotype control antibody. Showing variable profile from phalloidin 
staining. Some cells show typical F-actin filaments extending along the long axis of the cell. Others show clustering of F-actin to 
cell borders in regions of close intercellular contact. (B) Cultures prepared 3 h after challenged with anti-CD24 antibody. The 
majority of cells show intense staining for F-actin that is peripherally localized to cell borders. Bars, 20 μm.
  
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Ultrastructural changes associated with response to challenge with anti-CD24 antibody Figure 6
Ultrastructural changes associated with response to challenge with anti-CD24 antibody. Left panel showing cul-
ture fixed at 3 h after challenged with isotype control antibody. (A) en face section showing close intercellular contacts are 
mediated by cell processes that are not uniformly distributed. (B) Cross-section showing close intercellular contact confined to 
the basal region abutting the polyester membrane (arrows). (C) Showing higher magnification of long junction (box in B) with 
close membrane association. Right panel showing similar preparation of a culture challenged with anti-CD24 antibody. (D) En 
face section showing more uniform intercellular contacts mediated by cell processes. (E) Cross-section showing extensive 
intercellular communication mediated by extensive cell processes (arrow indicates supporting polyester membrane). (F) Show-
ing tight junction-like intercellular contact.
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Figure 7 (see legend on next page)
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RNA extraction and RT-PCR was carried out as described
previously [22]. The panel of target genes (see Table in
Additional file 1) for tight junction proteins was selected
on the basis of available literature for epithelia [21]. Prim-
ers were designed using Primer Express software (Perkin
Elmer, Foster City, CA) and synthesised by Sigma. Expres-
sion profiling PCR arrays for the target genes were ampli-
fied in a thermal cycler (FTS-320, Corbett Research,
Sydney, Australia) at 95°C, 15 min; 30 cycles of 95°C, 15
s; 60°C, 60 s. PCR array products (10 μl) from isotype
control antibody challenged and anti-CD24 antibody
challenged cultures were loaded into separate wells in a
2% agarose gel containing 0.5 μg/ml ethidium bromide in
1 × TAE buffer together with 5 μl of 100 bp DNA ladder
(Promega). The images of the gels on a UV Trans Illumi-
nator were captured by GeneSnap with CCD camera and
analyzed by Gene Tools' software from GeneGenius (Syn-
gene, MD, USA). Normalized values for relative intensity
of genes of interest were determined by dividing each of
the background-corrected RT-PCR band values by the
background-corrected value for the β-actin housekeeping
gene. Paired t-tests were used to analyse data from at least
three consecutive experiments. PCR products were puri-
fied with UltraClean PCR Clean-up Kit (Mobio Laborato-
ries, Inc., CA) and sequenced using respective forward
primers (Westmead DNA, Sydney, Australia) to confirm
sequence specificity of the amplicons.
Real-time (TaqMan) RT-PCR for altered gene expression: 
ZO-1, ZO-2, occludin, claudin-3, claudin-7, par-3 and par-
6
Real-time RT-PCR analyses were performed by TaqMan
assays using the ABI PRISM 7700 Sequence Detection Sys-
tem and software (Applied Biosystems, Inc., Foster City,
CA). The dual-labelled probes [shown in Additional file 1,
Table] were designed using Primer Express software (Per-
kin Elmer, Foster City, CA) and synthesised by Applied
Biosystems (probes labeled with fluorescent dyes 6-FAM
at 5' end and TAMRA at 3' end). TaqMan PCR Core Rea-
gent Kit and housekeeping gene β-actin kit were pur-
chased from Applied Biosystems (ABI, Foster City, CA) as
well. According to the kit protocol, 2 μl of diluted cDNA
samples, 200 nM of each probe, and 200 nM of respective
forward and reverse primers in a 25 μl final reaction mix-
ture were used. The PCR reaction was initiated by activa-
tion of AmpliTaq Gold at 95°C for 10 min, followed by
40 PCR cycles: denaturation at 95°C for 15 s, annealing
and extension at 60°C for 1 min. β-actin cDNA isolated
from H413 clone-1 cells was used for constructing stand-
ard curves (2000-2 pg). For TaqMan assays percentage
changes for target genes compared with β-actin controls
were analysed by paired t-tests. A level of P < 0.05 was
accepted as statistically significant.
Western blots for ZO-1, ZO-2, occludin, claudin-3, 
claudin-7 and par-6
Following adjustment via loading controls proteins
extracted in SDS sample buffer from H413 clone-1 cells
treated with isotype control antibody or mouse mono-
clonal antibody to CD24 peptide (5 μg/ml) for 3 h, were
separated by PAGE using 7.5% or 12% mini-gels, trans-
ferred to nitrocellulose membranes (Bio-Rad) and
blocked overnight with 3% bovine serum albumin
(Sigma) in 0.1 M Tris buffered salts solution pH 7.4 (TBS).
Blotted antigens were incubated with mouse monoclonal
anti-ZO-1 (1 μg/ml), ZO-2 (1 μg/ml), occludin (1 μg/ml),
claudin-7 (1 μg/ml) antibodies (ZYMED Laboratories,
Invitrogen) and mouse monoclonal anti-β-actin (0.2 μg/
ml) loading control antibody (Abcam Ltd., Cambridge,
UK) or rabbit polyclonal anti-claudin-3 (1 μg/ml), par-6
(1 μg/ml), and β-actin (0.1 μg/ml) loading control anti-
body (Abcam Ltd., Cambridge, UK) in 0.05% Tween20/
Down-regulation of CD24 expression by siRNA is associated with reduced expression of selected genes encoding tight junc- tion proteins Figure 7 (see previous page)
Down-regulation of CD24 expression by siRNA is associated with reduced expression of selected genes encod-
ing tight junction proteins. Data shown are representative of three independent experiments in each case. (A) Showing 
down-regulation of mRNA for CD24 in H413 clone-1 cells with two different inserts compared to control plasmid following 
30 cycles of RT-PCR. (B) Reverse transcription (RT)-PCR array (30 cycles) showing down-regulated gene expression of tight 
junction proteins for CD24 siRNA insert-1 silenced H413 clone-1 cells and compared to the cells transfected with control 
plasmid. Bands were visualized on a 2% agarose gel after staining with ethidium bromide. (C) Showing weaker suppression of 
expression of genes encoding tight junction proteins following transfection with the second CD24 siRNA insert that was less 
effective in suppressing CD24 expression (Fig. 7A). (D, E) Showing un-silenced CD24 following transfection by siRNA-3 (E) had 
no detectable effect on expression of genes encoding tight junction proteins as compared to plasmid control (D). [β-actin con-
trols in D also apply to E]. (F) Bar graph showing RT-PCR arrays (30 cycles) showing gene expression in CD24 siRNA-1 
silenced H413 clone-1 cells compared to plasmid control. Data are mean values from three independent experiments (± 
s.e.m.). The values for each experiment were normalized against the expression of β-actin (assigned as 100) and compared with 
the control sample by paired t-test. * Refers to P < 0.05; ND = not detected; five tight junction genes showed significant reduc-
tions that were confirmed by real-time quantitative RT-PCR analysis in Table 2. Expression of genes encoding claudin-3 and 
par-6 was not detected in either CD24 siRNA silenced cells or control plasmid culture samples by real-time quantitative RT-
PCR. All experiments were performed 48 h after transfection.BMC Cell Biology 2009, 10:2 http://www.biomedcentral.com/1471-2121/10/2
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TBS for 2 h, washed and incubated with alkaline phos-
phatase (AP)-conjugated second antibody (goat-anti
mouse or rabbit IgG, DAKO, Denmark) diluted 1:1500 in
Tween20/TBS for 2 h. Bound antibody was visualized
with AP substrate (Bio-Rad) after development of reactiv-
ity for proteins from isotype control antibody and anti-
CD24 antibody treated cultures under standardised con-
ditions.
Immunostaining and confocal laser scanning microscopy 
(CLSM) for ZO-1, ZO-2, occludin, claudin-3, claudin-7 and 
par-6
H413 clone-1 cells on Transwell filters (Corning) were
grown to confluence (cell density: 3.2 × 104/cm2) and
were randomly assigned to receive either isotype control
antibody or monoclonal antibody (5 μg/ml) to CD24
peptide for 3 h, washed in PBS then fixed with 4% para-
Down-regulation of CD24 by siRNA is associated with increased epithelial barrier disruption Figure 8
Down-regulation of CD24 by siRNA is associated with increased epithelial barrier disruption. Effect of silencing 
mRNA (insert-1) for CD24 in H413 epithelial monolayers. Regression data are representative of three independent experi-
ments for time points from triplicate cultures (showing mean values ± s.e.m.). For experiments commencing 48 h after trans-
fection, there is a significant difference between silenced and control cultures (paired t-test, * P < 0.05).
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formaldehyde/PBS for 15 min, permeabilized with 0.1%
Triton-X100/PBS for 15 min, and blocked with 10% horse
serum/PBS for 1 h. The filters were then cut into pieces
and placed in micro tubes (1.5 ml), then incubated over-
night at 4°C with rabbit anti-mouse IgG (Sigma) at 40 μg/
ml to block binding sites on mouse IgG that could have
remained attached to the cells as anti-CD24 peptide anti-
body. Following three wash cycles in 10% FCS/PBS, the
preparations were incubated with primary antibodies:
mouse monoclonal anti-ZO-1 (15 μg/ml), ZO-2 (1 μg/
ml), occludin (2 μg/ml) and claudin-7 (5 μg/ml) or rabbit
polyclonal anti-claudin-3 (5 μg/ml) and par-6 (5 μg/ml)
in 10% FCS/PBS at 30°C overnight in a humid chamber.
After washing with PBS, fluorochrome-conjugated second
antibody (goat anti-mouse or rabbit FITC, DAKO), was
added overnight at 4°C. For negative control, the primary
antibody was replaced with isotype control antibody
(DAKO). Membranes were washed with PBS and
mounted onto glass slides using ProLong Gold antifade
reagent with DAPI (Molecular Probes, Invitrogen).
Confocal images were captured with an Olympus
Fluoview (FV) 1000, equipped with Olympus FV 10-
MCPSU (405 nm, 473 nm, 633 nm) and NTT Electronic
Optiλ (559 nm) lasers, at Westmead Millennium Institute
confocal microscopy laboratory. Fields were selected at
random [objective: Olympus 60×/1.20/0.28 (WD) Water
UPLSAPO] and the cells were brought into focus under
bright-field conditions. All fluorescence images prepared
with confocal acquisition software (FV10-ASW 1.7) were
stored and exported as TIF image files.
Fluorescent phalloidin staining for F-actin
Cultures were established on Transwell membranes as
described for studies of paracellular permeability. Conflu-
ent cultures (3.2 × 104/cm2) were randomly assigned to
receive either monoclonal anti-CD24 antibody (5 μg/ml)
or isotype control antibody. After 3 h incubation cultures
were washed in PBS. For F-actin staining, cells were fixed
in 4% paraformaldehyde/PBS for 15 min, permeabilized
with 0.1% Triton-X100/PBS for 15 min, and blocked with
10% horse serum/PBS for 1 h. Membranes were stained
with FITC-Phalloidin (Sigma at 50 μg/ml) in FCS/PBS
with DAPI nuclear counterstain and examined by confo-
cal microscopy as described above.
Transmission electron microscopy (TEM)
For TEM analysis, cells prepared as for F-actin stain were
fixed in Karnovsky's fixative for 2 h followed by post-fixa-
tion in OsO4 for 1 h. Preparations were dehydrated in
graded alcohols and embedded in low viscosity resin
(TAAB Laboratory and Microscopy, United Kingdom).
Semi-thin sections were stained in Toluidine blue to facil-
itate the selection of site and orientation for preparation
of ultrathin sections in cross-section and en face. Sections
were mounted on Pioloform/formvar coated slot grids,
stained in uranyl acetate and lead citrate and examined in
a Phillips CM10 electron microscope. Film negatives were
scanned at 100% scale at 4000 pixels/inch using a Nikon
Super Coolscan 8000.
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